Conformal Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 48

Employees

  • Latest Deal Type
  • M&A

Conformal General Information

Description

Developer of a medical implant device designed to prevent stroke in patients with atrial fibrillation. The company's device addresses non-valvular atrial fibrillation and tailors its design to each patient's anatomy, meeting the demands of atrial appendage closure, enabling doctors and medical professionals to treat patients prone to strokes and save lives.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 15 Trafalgar Square
  • Suite 101
  • Nashua, NH 03063
  • United States
+1 (603)
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Parent Company
Corporate Office
  • 15 Trafalgar Square
  • Suite 101
  • Nashua, NH 03063
  • United States
+1 (603)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conformal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 21-Feb-2026 Completed Clinical Trials - General
4. Later Stage VC (Series D) 31-Jul-2025 Completed Clinical Trials - General
3. Later Stage VC (Series C) 06-Aug-2020 Completed Clinical Trials - General
2. Early Stage VC (Series B) 03-Dec-2018 $9M $13.9M Completed Clinical Trials - General
1. Early Stage VC (Series A) 04-Aug-2016 $4.95M $4.95M Completed Clinical Trials - General
To view Conformal’s complete valuation and funding history, request access »

Conformal Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B Non-voting
Series B
Series A Non-voting 4,444,444 $0.000100 8% $0.9 $0.9 1x $0.9 7.14%
Series A 4,026,633 $0.000100 8% $1 $1 1x $1 6.47%
To view Conformal’s complete cap table history, request access »

Conformal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical implant device designed to prevent stroke in patients with atrial fibrillation. The company's dev
Therapeutic Devices
Nashua, NH
48 As of 2025

Galway, Ireland
 

Burnaby, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Conformal Competitors (3)

One of Conformal’s 3 competitors is AuriGen Medical, a Venture Capital-Backed company based in Galway, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AuriGen Medical Venture Capital-Backed Galway, Ireland
Kardium Private Equity-Backed Burnaby, Canada
CardioFocus Venture Capital-Backed Marlborough, MA
You’re viewing 3 of 3 competitors. Get the full list »

Conformal Patents

Conformal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250025205-A1 Facilitating wire tracking across anatomical structures Pending 18-Jul-2023
US-20240382206-A1 Surgical left atrial appendage closure devices and methods for delivery Pending 15-May-2023
WO-2022182565-A1 Devices and methods for excluding the left atrial appendage Inactive 23-Feb-2021
US-20220265280-A1 Multifunctional left atrial appendage (laa) occluder Pending 19-Feb-2021
JP-2024133209-A Devices and methods for excluding left atrial appendage Pending 08-Feb-2019 A61B17/1219
To view Conformal’s complete patent history, request access »

Conformal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Conformal Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Physicians Fund Angel Group Minority
Catalyst Health Ventures Venture Capital Minority
Excelestar Ventures Venture Capital Minority
Fidelity Management & Research Company Asset Manager Minority
SPRIG Equity Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Conformal FAQs

  • When was Conformal founded?

    Conformal was founded in 2016.

  • Where is Conformal headquartered?

    Conformal is headquartered in Nashua, NH.

  • What is the size of Conformal?

    Conformal has 48 total employees.

  • What industry is Conformal in?

    Conformal’s primary industry is Therapeutic Devices.

  • Is Conformal a private or public company?

    Conformal is a Private company.

  • What is Conformal’s current revenue?

    The current revenue for Conformal is .

  • How much funding has Conformal raised over time?

    Conformal has raised $166M.

  • Who are Conformal’s investors?

    Angel Physicians Fund, Catalyst Health Ventures, Excelestar Ventures, Fidelity Management & Research Company, and SPRIG Equity are 5 of 6 investors who have invested in Conformal.

  • Who are Conformal’s competitors?

    AuriGen Medical, Kardium, and CardioFocus are competitors of Conformal.

  • When was Conformal acquired?

    Conformal was acquired on 21-Feb-2026.

  • Who acquired Conformal?

    Conformal was acquired by W. L. Gore and Associates.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process